AAMC CHARGE cultivates the health equity community by advancing collaborative research, policy, and programmatic solutions to health and health care inequities.
The vision of AAMC CHARGE is an equitable and just society in which academic health centers:
- Prioritize health equity scholarship and research across the full spectrum of scientific inquiry.
- Partner with communities, families, and patients to develop solutions to health injustice.
- Advocate for structural changes that address the root causes of health inequities.
AAMC CHARGE participants:
- Share accomplishments and crowdsource opportunities for professional achievement.
- Facilitate innovative multi-sector partnerships, collaborations, and research that contribute to the evidence base for solutions to health and health care inequities.
- Collaborate on policy work that impacts health equity at institutional, local, state, and federal levels.
Join AAMC CHARGE
Join AAMC CHARGE and connect with a vibrant community of health equity researchers and community partners. CHARGE participants receive alerts to new collaboration and advocacy opportunities, our monthly newsletter, AAMC Health Equity Research and Policy Update, and are invited to participate in the group’s online virtual community.
Just in Time Webinar: Hospital Contributions to Community Health Equity
The Bloomberg American Health Initiative and Johns Hopkins Center for Health Equity are proposing a measure to assess hospitals’ contributions to community health and equity. This measure is being developed with IBM Watson Health for potential inclusion in the Fortune/IBM Watson Health 100 Top Hospitals Program in 2021.
On September 8, AAMC CHARGE discussed and offered feedback on the draft measure during a Just in Time Webinar. Representatives from Johns Hopkins University facilitated the discussion and answered questions.
Looking for past AAMC CHARGE webinars?
Follow us on Vimeo to get notified when new recordings are posted.
Our Latest Policy and Advocacy Work
On May 29, 2020, the AAMC submitted comments to the Centers for Medicare and Medicaid Services (CMS) on rural maternal health disparities. In its comments, the AAMC encouraged CMS to leverage existing federal partnerships, partner with community-based stakeholders to address systemic issues, and invest in alternative care models.
On March 27, 2020, the AAMC submitted a response to a request for Stakeholder Input on Opportunities for Increased Collaboration to Advance Prevention Research from the National Institutes of Health (NIH) Office of Disease Prevention (ODP). The AAMC recommended ODP formalize its connections with nonprofit hospitals' population health efforts, and engage with other prevention and translational research programs and sites.
On February 25, 2020, the AAMC submitted comments to the Food and Drug Administration (FDA) on the development of strategic priorities for the Office of Minority Health and Health Equity (OMHHE). The AAMC recommended that the FDA and OMHHE collaborate and align research and communication practices across local, regional, and national, and minority organizations.
On February 21, 2020, the AAMC submitted comments to the National Institutes of Health (NIH) on its Proposed Research Initiative to Decrease Maternal Mortality. The AAMC urged the NIH to "identify evidence-based solutions which are translatable, effective, and can address the multiple health needs of mothers burdened by this crisis" through increased funding, alternative care models, and community engagement.
On February 3, 2020, the AAMC submitted comments to the National Institute on Minority Health and Health Disparities (NIMHD) at the National Institutes of Health on the social determinant of health (SDOH) measures proposed for inclusion in the Consensus Measures for Phenotypes and Exposures (PhenX) Toolkit. The AAMC recommended separate measures for community-level SDOH, individual-level, and health-related social needs (HRSN); measures that are accessible to, and useful for, measurement across diverse communities; and guidance concerning the ethical imperative researchers may have to refer participants who screen positive for serious HRSN and SDOH.
On October 25, 2019 the AAMC responded to a request for information from the National Center for Advancing Translational Sciences (NCATS) on improvements to the Clinical and Translational Science Awards (CTSA) Program: "The AAMC encourages NCATS to increase community engagement (CE)-focused funding to allow the CE cores to develop into “CE hubs” tasked, in part, with weaving together community- and patient-engaged efforts across the research, clinical, and training missions of their institutions."
On August 12, 2019 the AAMC submitted a comment letter to the HHS’ Office of Civil Rights that called for the withdrawal of its proposed changes to Section 1557 regulations because if the proposal is finalized it would eliminate all protections for transgender Americans as well as some for those with limited English proficiency. Section 1557 is intended to provide individuals with broad protections, ensuring that “an individual shall not . . . be excluded from participation in, be denied the benefits of, or be subject to discrimination under, any health care program or activity that is administered by an Executive Agency or any entity established under this title…”.
On August 6, 2019 the AAMC sent a letter to the Food and Drug Administration (PDF) on the agency’s request for information regarding the draft guidance Enhancing the Diversity of Clinical Trial Populations-Eligibility Criteria, Enrollment Practices, and Trial Designs. The AAMC offered comments regarding ways to broaden clinical trial eligibility requirements, improve clinical trial enrollment and retention, and use community engagement methods to increase patient participation.
On August 5, 2019 the AAMC sent a letter to the Office of Science and Technology Policy (OSTP) (PDF) to inform the development of the National Research Strategy for the President’s Roadmap to Empower Veterans and End the National Tragedy of Suicide. AAMC offered recommendations to improve the ability to identify individual veterans and groups of veterans at greater risk of suicide and to develop public-private collaboration models to foster innovative and effective research.